MolNFT v1 · #144228 · DNA
Binding of an antitumor drug to DNA. netropsin and C-G-C-G- a-a-T-T-brc-G-C-G
6BNA · DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(CBR) P*GP*CP*G)-3'): “Binding of an antitumor drug to DNA. netropsin and C-G-C-G- a-a-T-T-brc-G-C-G”. X-ray diffraction, 1 ligand (NT), 1 pocket (best druggability 0.26). MolNFT v1 #144228 on…
- PDB
- 6BNA
- Type
- DNA
- Length
- 24 nucleotides
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(CBR) P*GP*CP*G)-3')
- Ligands
- NT
- Pockets
- 1 · best druggability 0.26
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | DNA (5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*(CBR) P*GP*CP*G)-3') | dna | 12 | — | — |
Ligands and binding sites
- NT · Netropsin · ligand · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 59 | 0.26 | 0.73 | 15 | NT |
Interfaces
1 interface between chains.
- A–B · 580 Ų buried · 61 hydrogen bonds · nucleic-nucleic
Modifications
Observed in the structure: 2 modified (nucleotide modification).
Compared structures
- 6BNA · Binding of an antitumor drug to DNA. netropsin and C-G-C-G-a-a-T-T-brc-G-C-G · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Elsewhere: RCSB PDB 6BNA · PDBe 6BNA
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.